Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS)



Status:Recruiting
Conditions:Lupus
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:3/14/2019
Start Date:June 28, 2017
End Date:June 30, 2022
Contact:AstraZeneca Clinical Study Information Center
Email:information.center@astrazeneca.com
Phone:1-877-240-9479

Use our guide to learn which trials are right for you!

Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS): Prospective Observational Cohort of Patients With Moderate-to-severe SLE to Characterize Cross-sectional and Longitudinal Disease Activity, Treatment Patterns and Effectiveness, Outcomes and Comorbidities, Healthcare Resource Utilization, and the Impact of SLE on Quality of Life by Type I Interferon Expression

SPOCS is an international, multicenter, prospective observational cohort study with bi-annual
study visits over a 3-year follow-up designed to systematically describe the comprehensive
SLE patient-journey regarding clinical features, disease progression and treatment patterns,
SLE outcomes, health status assessments (PROs), and health care resource utilization (HCRU)
in a general population of moderate-to-severe SLE patients.

SPOCS is an international, multicenter, prospective observational cohort study with bi-annual
follow-up over 3-years maximum follow-up of patients with SLE confirmed by American College
of Rheumatology (ACR) or Systemic Lupus International Collaborating Clinics (SLICC)
classification criteria, who have moderate-to-severe disease by SLEDAI-2K criteria (Modified
SLEDAI-2K score ≥4 and/or SLEDAI-2K score ≥6 points, at least one life-time positive serology
of anti-nuclear antibody (ANA) or double-stranded deoxyribonucleic acid antibody (dsDNA), and
6-month minimum treatment duration with systemic SLE treatment beyond NSAIDS and analgesics.
Participants will be followed as per local routine clinical practice. SPOCS is an
observational study with no requirement for protocolized treatment interventions.

Inclusion Criteria:

Patients must meet the following criteria for enrollment in SPOCS:

- Adult patients aged 18 years or older

- Physician confirmation that patient meets ACR or SLICC SLE classification criteria

- Current or historic positive serology of ANA or dsDNA

- Minimum treatment duration of 6 months for active SLE with systemic SLE treatment
beyond NSAIDs and analgesics

- Moderate-to-severe SLE; SLEDAI-2K Criteria: Modified SLEDAI-2K score ≥4 and/or
SLEDAI-2K score ≥6. The "Modified" SLEDAI-2K is the SLEDAI-2K assessment score without
the inclusion of points attributable to any urine or laboratory results including
immunologic measures and lupus headache.

- Patient and/or representative(s) who understands the requirements of the study and
provides written informed consent.

Exclusion Criteria:

Patients meeting any of the following criteria will be determined to be ineligible for
enrollment in SPOCS:

- Patients actively enrolled in interventional trials involving investigational agents

- Patient with active severe lupus nephritis with a history of a renal biopsy in the
last year showing active class III or class IV +/- class V lupus nephritis and/or
urine protein:creatinine ratio >1mg/mg based on random urine collection.

- Patients unable to complete study measures
We found this trial at
31
sites
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Beverly Hills, California 90211
?
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
?
mi
from
Bronx, NY
Click here to add this to my saved trials
?
mi
from
Canberra,
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Coeur D'Alene, ID
Click here to add this to my saved trials
?
mi
from
Dallas, TX
Click here to add this to my saved trials
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Duncansville, Pennsylvania 16635
?
mi
from
Duncansville, PA
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
El Cajon, CA
Click here to add this to my saved trials
?
mi
from
Great Neck, NY
Click here to add this to my saved trials
Greensboro, North Carolina 27401
?
mi
from
Greensboro, NC
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
?
mi
from
Jonesboro, AR
Click here to add this to my saved trials
?
mi
from
Loma Linda, CA
Click here to add this to my saved trials
?
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
Mission Viejo, California 92691
?
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
?
mi
from
Nashua, NH
Click here to add this to my saved trials
?
mi
from
Newark, NJ
Click here to add this to my saved trials
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
?
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
?
mi
from
Spokane, WA
Click here to add this to my saved trials
?
mi
from
Tamarac, FL
Click here to add this to my saved trials
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
?
mi
from
West Hills, CA
Click here to add this to my saved trials